Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Genecis
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of bacterial technology to turn food waste into polyhydroxyalkanoates (PHAs), a high-quality bioplastic

Founded in 2016
Founded in

Company type Private Public ()
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Toronto, ON Toronto, Canada
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Cleantech Group on 09/29/2023

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
12/16/2021
PHAradox PHAradox
The companies will develop various resin formulations that include Genecis’ PHAs for high-value applications, such as 3D printing filaments and biomedical applications.
View source    
Confirmed by PHAradox
Development Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Cancel Save
Add Investment
Date Investors Type Amount
06/14/2023 Ontario Genomics Ontario Genomics (1)
Post-money valuation of
Each startup selected for the BioCreate program will receive c$150,000 of non-repayable funding from Ontario Genomics, which companies have to match with a c$100,000 minimum contribution. Participants will also go through 18 months of mentorship and gain access to infrastructure for their technology and business development.
 Grant $113,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font